SNDL
SNDL · NASDAQ
About SNDL
- Employees
- 2,751
- Headquarters
- Calgary, Alberta
- Listed
- Aug 1, 2019
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Website
- sndl.com
SNDL key statistics
- Market cap
- 315.03M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 1.35M
- Volume
- 960.37K
- Open price
- $1.25
- High today
- $1.29
- Low today
- $1.25
- 52 Week high
- $2.40
- 52 Week low
- $1.13
SNDL (SNDL) at a glance
SNDL (SNDL) last traded at $1.28, with a market cap of 315.03M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $1.25 and $1.29. The current price is 2.8% above the day's low and 0.5% below its high.
Volume so far is 960.37K shares, below the average of 1.35M shares a day.
Over the past year SNDL has ranged from $1.13 to $2.40, and now sits 12% of the way up that range.
SNDL met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported -$0.03 per share against an estimate of -$0.0051.
SNDL earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 208.1% on average.
- Q3 FY24: reported -$0.07 per share against an estimate of -$0.051
- Q4 FY24: reported $0.05 per share against an estimate of -$0.0204
- Q1 FY25: reported -$0.03 per share against an estimate of -$0.0816
- Q2 FY25: reported $0.01 per share against an estimate of -$0.051
- Q3 FY25: reported -$0.0563 per share against an estimate of -$0.0306
- Q4 FY25: reported $0.0408 per share against an estimate of -$0.0102
- Q1 FY26: reported -$0.04 per share against an estimate of -$0.0459
- Q2 FY26: reported -$0.03 per share against an estimate of -$0.0051
SNDL news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
SNDL Announces Successful Completion of EU-GMP Audit at Atholville Facility
- Press releaseGlobe Newswire
SNDL Reports Second Quarter 2026 Financial and Operational Results
- Press releaseGlobe Newswire
SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations
- Erica Kollmann
Trulieve Makes History As First US Cannabis Stock On NYSE
- Press releaseGlobe Newswire
SNDL Announces Update on Arrangement Agreement with 1CM for Acquisition of Ontario Cannabis Stores
- Press releaseGlobe Newswire
Multibillion-Dollar Edibles Market Gains Rising Momentum as Legalization Expands
- Henry Khederian
SNDL Stock Slides On Q1 Revenue Miss, Soft Market Demand
Similar companies
Companies in the same industry as SNDL
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.